Evidence map›Paper›PMID 39535169›Full record

ArticleJournal of biomolecular structure & dynamics2025

Molecular dynamics simulations provide insights into ULK-101 potency and selectivity toward autophagic kinases ULK1/2.

Robert M Vaughan, Bradley M Dickson, Katie R Martin, Jeffrey P MacKeigan

Abstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Robert M VaughanPediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
Bradley M DicksonDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA.
Katie R MartinPediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
Jeffrey P MacKeiganPediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.

Funding

Evaluating a Novel Autophagy Inhibitor in KRAS-Driven Lung CancerR21CA252430 · NCI · MICHIGAN STATE UNIVERSITY · PI MACKEIGAN, JEFFREY PAUL · 2021 to 2021
$402k
Therapeutic potential of targeting DNA repair deficiency in TSCR21CA263133 · NCI · MICHIGAN STATE UNIVERSITY · PI MACKEIGAN, JEFFREY PAUL · 2021 to 2022
$399k
ULK1 Inhibitor in Combination with Immune Checkpoint Blockade in PancreaticCancerR21CA270588 · NCI · MICHIGAN STATE UNIVERSITY · PI MACKEIGAN, JEFFREY PAUL · 2023 to 2024
$393k
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis ComplexK00CA245821 · NCI · MICHIGAN STATE UNIVERSITY · PI VAUGHAN, ROBERT MARK · 2021 to 2024
$374k
NCI NIH HHS K00 CA245821NCI NIH HHS R21 CA252430NCI NIH HHS R21 CA263133NCI NIH HHS R21 CA270588
6 · The paper itself

Abstract

Kinase domains are highly conserved within proteins in both sequence and structure. Many factors, including phosphorylation, amino acid substitutions or mutations, and small molecule inhibitor binding, influence conformations of the kinase domain and enzymatic activity. ULK1 and ULK2 are serine/threonine kinases that serve important roles in autophagy, an intracellular recycling process capable of degrading proteins and organelles

Indexed as

AutophagyAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsMolecular Dynamics SimulationProtein Kinase InhibitorsProtein Serine-Threonine KinasesAdenosine TriphosphateBinding SitesHumansHydrogen BondingProtein BindingProtein ConformationAdenosine TriphosphateAutophagy-Related Protein-1 HomologIntracellular Signaling Peptides and ProteinsProtein Kinase InhibitorsProtein Serine-Threonine KinasesULK1 protein, humanUlk2 protein, humanadaptive biasingautophagykinasemolecular dynamics simulationssmall molecule inhibitorULK1ULK-101ULK2

Identifiers

PMID39535169
PMCPMC12069652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.